Public-private mix for TB and TB-HIV care in Lagos, Nigeria.
METHODS
Private and public tuberculosis (TB) treatment centres in Lagos State, Nigeria.


OBJECTIVE
To assess the contribution of private health care providers to TB and TB-HIV (human immunodeficiency virus) case finding in Lagos State.


METHODS
A retrospective review of programme data submitted to the Lagos State TB and Leprosy Control Programme in 2011 by public, private for-profit (PFP) and private not-for-profit (PNFP) health care providers.


RESULTS
A total of 8425 TB cases were notified by 31 private (11 PFP and 20 PNFP) and 99 public health facilities in Lagos State. Overall, the private facilities were responsible for 10.3% (866/8425) of the total TB cases notified. The proportion of TB patients tested for HIV was respectively 86.2%, 53.1% and 96.5% among public, PFP and PNFP facilities. Overall, 22.4% of the TB patients were HIV-positive. The HIV positivity rate among public, PFP and PNFP facilities was respectively 23.8%, 7.8% and 9.9%. Uptake of cotrimoxazole preventive therapy was respectively 69.6%, 25% and 38.2% among public, PFP and PNFP facilities, while that of antiretroviral therapy was respectively 23.8%, 8.3% and 9.1% in public, PFP and PNFP facilities.


CONCLUSIONS
There is a need to scale up collaboration with the private sector, and particularly PNFP health providers.
Department of Community Medicine and Primary Care, Olabisi Onabanjo University Teaching Hospital Sagamu, Ogun State, Nigeria. sojidaniel@yahoo.com
O J
OJ
Daniel
O
O
Adedeji Adejumo
H A
HA
Abdur-Razzaq
E
E
Ngozi Adejumo
A A
AA
Salako
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D060085:Coinfection; D003299:Cooperative Behavior; D019033:Delivery of Health Care, Integrated; D023801:Directly Observed Therapy; D018563:Disease Notification; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D006777:Hospitals, Proprietary; D006788:Hospitals, Voluntary; D006801:Humans; D007373:Interinstitutional Relations; D009549:Nigeria / Q000453:epidemiology; D010818:Practice Patterns, Physicians'; D017149:Private Sector; D011634:Public Health; D055818:Public-Private Sector Partnerships; D012189:Retrospective Studies; D016896:Treatment Outcome; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D014376:Tuberculosis / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D019037:Urban Health Services
D019380:Anti-HIV Agents; D000995:Antitubercular Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination